• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Elucidation of Molecular Mechanism of Muscle Degenaration using Developmental Biology Technique and development of therapeutics

Research Project

Project/Area Number 10557065
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section展開研究
Research Field Neurology
Research InstitutionNational Institute of Neuroscience, NCNP

Principal Investigator

TAKEDA Shin'ichi  Department of Molecular Therapy, National Institute of Neuroscience, Therapy NCNP, 神経研究所・遺伝子疾患治療研究部, 部長 (90171644)

Co-Investigator(Kenkyū-buntansha) SUZUKI Yuko  Department of Molecular Therapy, National Institute of Neuroscience, NCNP, Section chief, 神経研究所・遺伝子疾患治療研究部, 室長(研究職)
HANAOKA Kazunori  KITAZATO UNIVERSITY, National Institute of Neuroscience, NCNP, Professor, 大学理学部・分子発生, 教授 (40189577)
Project Period (FY) 1998 – 2000
Keywordsmerosin-deficient congenital muscular dystrophy / merosin / laminin α2 chain / dy^<3K> / dy^<3K>mice / laminin M chain / apoptosis / αdystroglycan / integrin
Research Abstract

Laminin-2(merosin), composed of α2, β1 and γ1 chains, is a major comnponent of skeletal muscle basal lamina. Murarions of the laminin α2 chain gene cause merosin-deficient congenital muscular dystrophy(MD-CMD). To clarify the molecular pathology of
Laminin-2(merosin), composed of α2, β1 and γ1 chains, is a major comnponent of skeletal muscle basal lamina. Murarions of the laminin α2 chain gene cause merosin-deficient congenital muscular dystrophy(MD-CMD). To clarify the molecular pathology of MD-CMD, we generated lamininarufα2 chain knock out mouse(dy^<3K>), where the expression of laminin α2 chain is completely absent. The dy^<3K>revealed typical phenotype of muscular dystrophy, therefore the mouse is accepted as an ideal model of MD-CMD at date. We precisely ezamined morphological changes of the sleletal muscle of dy^<3K>/dy^<3K>mice. On postnatal day 9(P9) a few fibers showed necrotic changes, but on P10 manuy necrotic fibers were seen. In this stage, Evans Blue dye IgG influx into muscle fibers were found along necrotic changes of muscle fibers. Several fibers began to regenerate on P11, nad numerous regenerating fibers appeared on P13. In this stage, canpase-3 antivation and TUNEL-posotive myonuclei were found in manyu regeneratin fibers. Dephosphorylation of Bad, which triggers apoptotic signaling cascade, was also detected, suggesting that the absence of laminin α2 chain results in apoptosis of early regfenerating fibers through the interruption of survival signal from the extracellular matrix. Imcomplete or abortive regenarating process. The mouse also showed incomplete myelination in peripheral nervous system and maturational abnomality in the immunne system.

  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Iwao M et al.: "Thymic atrophy in laminin-alpha-2 chain deficient mice is a result of ..."Immunology. 99. 481-488 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ikemoto M et al.: "Space shuttle flight (STS-90) enhances degradation of rat myosin heavy..."Microscopy Research and Technique. 48. 181-191 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yokota T et al.: "Aquaporin-4 is absent at the sarcolemma and at perivascular astrocyte..."Proc.Japan Acad. 76B. 22-27 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamamoto K et al.: "Immune response to adenoviral-delivered antigens upregulates utrophin....."Human Gene Therapy. 11. 669-680 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 宮越友子,武田伸一: "筋衛星(サテライト)細胞と遺伝子性筋疾患の遺伝子治療"神経研究の進歩. 45. 54-62 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 武田伸一: "ポストゲノム医療の展望:総論 神経疾患"日本臨床. 59. 19-30 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 武田伸一, 他: "筋肉細胞、遺伝子治療開発ハンドブック"株式会社 エヌ・ティー・エス. 1061 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miyagoe Y, Hanaoka K, Nonaka I, Hayasaka M, Nabeshima Y, Arahara K, Nabeshima Y and Takeda S: "Laminin α2 chain-null mutant mice by targeted disruption of the LAMA2 gene : A new model of merosin (laminin 2)-deficient congenital muscular dystrophy"FEBS Lett. 415. 33-39 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Miyagoe-Suzuki Y, Nakagawa M and Takeda S: "Merosin and congenital muscular dystrophy"Microsc Res Tech. 48. 181-191 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Iwao M, Fukada S-I, Tsujikawa K.Yagita H, Miyagoe Y, Takeda S, and Yamamoto H: "Thymic arrophy in laminin-alpha-2 chain deficient mice is a result of selective death of CD4^+8S^+ immature thymocytes"Immunology. 99. 481-488 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi